bromocriptine


Also found in: Dictionary, Medical, Wikipedia.
Related to bromocriptine: Cabergoline

bromocriptine

[‚brō·mō′krip‚tēn]
(organic chemistry)
C32H40BrN5O5 A polypeptide alkaloid that is a derivative of the ergotoxin group of ergot alkaloids and is a dopamine receptor agonist.
Mentioned in ?
References in periodicals archive ?
Inoue T Tsuchiya K, Miura J, Sakakibara S, Denda K, Kasahara T Koyama T Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression.
Major finding: The proportional reporting ratio, similar to the relative risk ratio, was significant between pramipexole, ropinirole, cabergoline, bromocriptine, rotigotine, and apomorphine on one hand, and a variety of impulse control disorders on the other.
So we decided to start the bromocriptine as we had nothing to lose.
Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
Another therapeutic conundrum relates to the paradoxical finding that the dopaminergic agonist bromocriptine induces stronger activation of brain reward circuitry in individuals who carry the DRD2 A1 allele compared with DRD2 A2 allele carriers.
Based on the positive report of Stewart [11], bromocriptine was considered, but after 1 week, her restlessness resolved spontaneously.
The third group received bromocriptine (purchased from Sigma-Aldrich Company, USA) (ip) (0.
Drugs such as tamoxifen, danazol and bromocriptine are effective agents but have significant side-effects and should only be prescribed by specialists.
Several dopamine agonists are currently available for the treatment of hyperprolactinemia, including bromocriptine and cabergoline in the USA and, additionally, quinagolide in the UK and most other European countries (2,4).
Bromoeriptine, a dopamine D2 receptor agonist, (l-10 mg/kg, os) significantly and in a dose dependent manner, reduced the serum prolactin levels; bromocriptine, at the dose of 1 trig/kg, significantly reduced the high serum prolactin levels induced by Silymarin BIO-C[R].
There is less experience with cabergo-line, today's treatment of choice, than with the former first-line agent bromocriptine.